Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsStem Cell TransplantationBlood Component RemovalMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsStem CellsMyeloablative AgonistsBusulfanGraft vs Host DiseaseHematopoietic Stem CellsBone Marrow TransplantationTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCytarabineCord Blood Stem Cell TransplantationHodgkin DiseaseDisease-Free SurvivalTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsSurvival RateWhole-Body IrradiationTime FactorsInfectionSurvival AnalysisLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountHistocompatibility TestingPrednisoneCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineBlood Cell CountRecombinant ProteinsLeukemiaFollow-Up StudiesBone Marrow PurgingAntineoplastic AgentsEmbryonic Stem CellsBlood CellsLymphomaCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectBone MarrowFatal OutcomeBone and BonesFeasibility StudiesAdult Stem CellsMesenchymal Stem Cell TransplantationImmunophenotypingMyelodysplastic SyndromesAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow CellsBlood Transfusion, AutologousLymphocyte DepletionLiver TransplantationT-LymphocytesCell SeparationLeukocytes, MononuclearCell DifferentiationHematologic DiseasesPluripotent Stem CellsHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsLivedo ReticularisFlow Cytometry